Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 122.24 | 100.48 | 95.94 | 83.72 |
Depreciation/ Depletion | 10.62 | 9.17 | 8.09 | 7.56 |
Non- Cash Items | -27.75 | -8.56 | -5.88 | -2.46 |
Changesin Working Capital | -41.90 | -61.83 | -22.01 | -19.55 |
Cashfrom Operating Activities | 63.22 | 39.26 | 76.13 | 69.27 |
Capital Expenditures | -39.61 | -14.28 | -45.53 | -8.75 |
Other Investing Cash Flow Items Total | -17.73 | -22.36 | -32.56 | -55.48 |
Cashfrom Investing Activities | -57.34 | -36.64 | -78.08 | -64.23 |
Financing Cash Flow Items | -1.27 | -1.35 | -1.04 | -1.19 |
Total Cash Dividends Paid | -3.00 | -3.00 | -3.00 | 0.00 |
Issuance( Retirement)of Debt Net | -0.90 | -0.14 | 1.48 | -4.55 |
Cashfrom Financing Activities | -5.18 | -4.50 | -2.56 | -5.75 |
Net Changein Cash | 0.70 | -1.88 | -4.50 | -0.70 |
Cash Interest Paid | 1.27 | 1.35 | 1.04 | 1.19 |
Cash Taxes Paid | 26.15 | 29.61 | 23.70 | 19.49 |
Lincoln Pharmaceuticals Dividend Lincoln Pharmaceuticals Bonus Lincoln Pharmaceuticals News Lincoln Pharmaceuticals AGM Lincoln Pharmaceuticals Rights Lincoln Pharmaceuticals Splits Lincoln Pharmaceuticals Board Meetings Lincoln Pharmaceuticals Key Metrics Lincoln Pharmaceuticals Shareholdings Lincoln Pharmaceuticals Profit Loss Lincoln Pharmaceuticals Balance Sheet Lincoln Pharmaceuticals Q1 Results Lincoln Pharmaceuticals Q2 Results Lincoln Pharmaceuticals Q3 Results Lincoln Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks